Concepedia

Nobuko Nishimura

NN

Statistics

Publications

23

Citations

1.5K

H-Index

19

Active since

1987

Affiliations

Amgen (United States)(Current)

University of California, Los Angeles

Hitachi (Japan)

Nobuko Nishimura is an author at Amgen (United States) specializing in medicine, natural sciences, and drug discovery.

Top concepts

Publications per year

1987–2022

23

Publications

23

Discovery of a Covalent Inhibitor of KRAS<sup>G12C</sup> (AMG 510) for the Treatment of Solid Tumors

Brian A. Lanman, Jennifer R. Allen, John G. Allen et al. · Journal of Medicinal Chemistry · 2019 · 677 citations · Full text

, , +20

Species-Specific Pharmacology of Trichloro(Sulfanyl)ethyl Benzamides as Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists

Lana Klionsky, Rami Tamir, BaoXi Gao et al. · Molecular Pain · 2007 · 109 citations · Full text

Novel Vanilloid Receptor-1 Antagonists:  3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties

Huiling Wang, Jodie Katon, Balan Chenera et al. · Journal of Medicinal Chemistry · 2007 · 71 citations · Full text

, , +13

Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure–Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives

Nobuko Nishimura, Aaron Siegmund, Longbin Liu et al. · Journal of Medicinal Chemistry · 2011 · 59 citations · Full text

Fused Piperidines as a Novel Class of Potent and Orally Available Transient Receptor Potential Melastatin Type 8 (TRPM8) Antagonists

Nuria Tamayo, Yunxin Bo, Vijay Gore et al. · Journal of Medicinal Chemistry · 2012 · 55 citations · Full text

1–5 of 23